NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Prosigna breast cancer prognostic gene ...
Biopharmaceutical company Galena Biopharma has announced patent notification from the European Patent Office for pharmaceutical use of NeuVax (nelipepimut-S) as a vaccine for the prevention of relapse in breast cancer patients. The patent ...
Tags: Galena Biopharma, Neuvax
On Tuesday, the US Department of Commerce (DOC) announced the final results of its expedited sunset review of the antidumping (AD) orders on light-walled rectangular pipe and tube from China, Korea, Mexico, and Turkey. As expected, the ...
Tags: Light-Walled Pipe
On Thursday, the US Department of Commerce (DOC) announced the final results of its expedited sunset review of the countervailing duty (CVD) order on light-walled rectangular pipe and tube from China. As expected, the DOC determined that ...
Tags: Light-Walled Pipe
Castle Biosciences has announced that data from studies of its DecisionDx-Melanoma test confirm previous studies, indicating that the gene expression profile test is a strong predictor for classifying which Stage I or II non-metastatic ...
Researchers at A*STAR’s Genome Institute of Singapore (GIS) have identified potential targets for therapeutic drugs against aggressive breast cancer. Working in collaboration with local and international institutions, GIS scientists ...
Tags: therapeutic drugs, Medicine
On Tuesday, the US International Trade Commission (ITC) issued its formal decision in the second sunset review of the antidumping orders against steel concrete reinforcing bars from Belarus, China, Indonesia, Latvia, Moldova, Poland, and ...
US-based NanoString Technologies has announced that its Prosigna Breast Cancer Prognostic Gene Signature Assay offers better prognostic information in endocrine treated patients with HR+ node negative disease. NanoString Technologies said ...
Tags: Prognostic Information, Medicine
US-based NanoString Technologies has announced that its Prosigna Breast Cancer Prognostic Gene Signature Assay offers better prognostic information in endocrine treated patients with HR+ node negative disease. NanoString Technologies said ...
Tags: Prognostic Information, Medicine
The Mexican Ministry of Economy reported last week that after completing the review process initiated by Deacero on July 18, 2012, the ministry decided to maintain the antidumping duty of US$0.45 per kilogram of steel wire mesh imported ...
The United States determined June 18 it would maintain the existing anti-dumping duty on imports of sodium hexametaphosphate from China, despite Beijing's repeated calls for Washington to drop trade protectionism. The US International ...
Chengdu Huasun Group Inc., Ltd. (SZSE: 000790) announced yesterday that its biological tech subsidiary has been supported by China in doing an anticancer research. The research is concerned with the utilization of Iodine [131I] Metuximab ...
Tags: Health, Medicine, Anticancer Product
LED Medical Diagnostics, a developer of tissue fluorescence visualization technologies, has announced that its patented VELscope Vx oral examination device is presently involved in a Phase III study, which is sponsored by the University of ...
Tags: Oral Cancer Study, Medicine
Inostics, a molecular diagnostics firm providing blood-based mutation testing, has received the Clinical Laboratory Improvement Amendments (CLIA) license for its clinical laboratory in Baltimore. The receipt of the license would mark a ...
Tags: Clia Certification, Medicine
Salix Pharmaceuticals has acquired the worldwide intellectual property rights relating to Olon’s amorphous rifaximin. A pending patent application covering amorphous rifaximin, an issued patent covering the product along with ...
Tags: Salix, Amorphous Rifaximin